Increasing evidence suggests that obesity-related insulin/IGF signaling pathways may promote invasion and metastasis, three of the ten characteristics of cancer, by maintaining proliferative signaling, evading apoptosis (or fighting cell death), and sustaining proliferative signaling [88]. The gene discussed is IGF1; the disease is cancer.